Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a minor update to the study record (likely QC or formatting adjustments) without substantive changes to the study details.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page gains new study metadata and documentation, including sponsor and investigators, collaborators, and links to the Study Protocol and SAP, as well as IPD sharing information and related MeSH terms.SummaryDifference73%

- Check33 days agoChange DetectedNo additions or deletions were provided in the data, so there is no change to evaluate. The study details content remains as documented on the page.SummaryDifference0.0%

- Check41 days agoChange DetectedThe Study Details page gains recruitment status and guidance sections (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision to v3.6.0; the existing 'Intervention/Treatment' section is removed and the prior v3.5.5 revision note is eliminated.SummaryDifference0.4%

- Check48 days agoChange DetectedRevision label on the page updated from v3.5.4 to v3.5.5, reflecting a recent site deployment.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4. This appears to be a minor metadata/template update with no effect on the study details or user-facing information.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.